Truist lowered the firm’s price target on Molina Healthcare (MOH) to $340 from $370 and keeps a Buy rating on the shares. The firm is adjusting its model after the company’s Q4 earnings miss and below-consensus initial FY25 guide, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Molina Healthcare’s Growth at Risk: Navigating Restrictive Credit Covenants
- Molina Healthcare price target lowered to $342 from $378 at TD Cowen
- Buy Rating for Molina Healthcare: Strategic Growth Amidst Challenges
- Trump Trade: President advocates to close carried interest tax loophole
- Molina Healthcare price target lowered to $356 from $406 at Cantor Fitzgerald